8ABN

Solution structure of a phenyl-indoloquinoline intercalating into a quadruplex-duplex hybrid

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H NOESY	0.64 mM no PIQ-QD2l	90% H2O/10% D2O	120 mM	7.0	1 atm	303	Bruker AVANCE NEO 600
2	2D 1H-1H COSY	0.64 mM no PIQ-QD2l	90% H2O/10% D2O	120 mM	7.0	1 atm	303	Bruker AVANCE NEO 600
3	2D 1H-1H TOCSY	0.64 mM no PIQ-QD2l	90% H2O/10% D2O	120 mM	7.0	1 atm	303	Bruker AVANCE NEO 600
4	2D 1H-13C HSQC	0.64 mM no PIQ-QD2l	90% H2O/10% D2O	120 mM	7.0	1 atm	303	Bruker AVANCE NEO 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE NEO	600

NMR Refinement
Method	Details	Software
simulated annealing		Amber

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	10
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	Amber	18	Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman
2	structure calculation	X-PLOR NIH	3.0.3	Schwieters, Kuszewski, Tjandra and Clore
3	chemical shift assignment	CcpNmr Analysis	2.4.2	CCPN
4	processing	TopSpin	4.0.7	Bruker Biospin
5	data analysis	CcpNmr Analysis	2.4.2	CCPN
6	peak picking	CcpNmr Analysis	2.4.2	CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.